125 related articles for article (PubMed ID: 11300367)
1. Quinaprilat-induced vasodilatation in forearm vasculature of patients with essential hypertension: comparison with enalaprilat.
Houben AJ; Kroon AA; de Haan CH; Fuss-Lejeune MJ; de Leeuw PW
Cardiovasc Drugs Ther; 2000 Dec; 14(6):657-63. PubMed ID: 11300367
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of quinaprilat and enalaprilat on endothelial function of conduit arteries in patients with chronic heart failure.
Hornig B; Arakawa N; Haussmann D; Drexler H
Circulation; 1998 Dec 22-29; 98(25):2842-8. PubMed ID: 9860785
[TBL] [Abstract][Full Text] [Related]
3. Quinaprilat induces arterial vasodilation mediated by nitric oxide in humans.
Haefeli WE; Linder L; Lüscher TF
Hypertension; 1997 Oct; 30(4):912-7. PubMed ID: 9336392
[TBL] [Abstract][Full Text] [Related]
4. Improvement of bradykinin endothelium-mediated vasodilation of forearm resistance circulation by quinaprilat in patients with coronary artery disease with or without left ventricular dysfunction.
Benacerraf S; Carville C; Adnot S; Montagne O; Sediame S; Belhassen L; Dubois-Randé JL
J Cardiovasc Pharmacol; 1999 Sep; 34(3):368-73. PubMed ID: 10470994
[TBL] [Abstract][Full Text] [Related]
5. [Hemodynamic and humoral effects of parenteral therapy with intravenously administered ACE inhibitor quinaprilat in patients with advanced heart failure].
Mitrovic V; Mudra H; Bonzel T; Schmidt W; Schlepper M
Z Kardiol; 1996 Nov; 85(11):828-38. PubMed ID: 9064945
[TBL] [Abstract][Full Text] [Related]
6. Tissue inhibition of angiotensin-converting enzyme activity stimulates angiogenesis in vivo.
Fabre JE; Rivard A; Magner M; Silver M; Isner JM
Circulation; 1999 Jun; 99(23):3043-9. PubMed ID: 10368123
[TBL] [Abstract][Full Text] [Related]
7. High tissue affinity angiotensin-converting enzyme inhibitors improve endothelial function and reduce infarct size.
Lazar HL; Bao Y; Rivers S; Colton T; Bernard SA
Ann Thorac Surg; 2001 Aug; 72(2):548-53; discussion 553-4. PubMed ID: 11515896
[TBL] [Abstract][Full Text] [Related]
8. The effect of local angiotensin converting enzyme inhibition on the action of atrial natriuretic peptide in the human forearm.
Cockcroft JR; Allen MJ; Benjamin N; Webb DJ
J Hum Hypertens; 1989 Feb; 3(1):49-52. PubMed ID: 2542549
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of quinaprilat, an active metabolite of quinapril, on Ca2+-overload induced by lysophosphatidylcholine in isolated rat cardiomyocytes.
Ma H; Hashizume H; Hara A; Yazawa K; Abiko Y
Jpn J Pharmacol; 1999 Jan; 79(1):17-24. PubMed ID: 10082313
[TBL] [Abstract][Full Text] [Related]
10. A pharmacodynamic and pharmacokinetic comparison of intravenous quinaprilat and oral quinapril.
Breslin E; Posvar E; Neub M; Trenk D; Jahnchen E
J Clin Pharmacol; 1996 May; 36(5):414-21. PubMed ID: 8739020
[TBL] [Abstract][Full Text] [Related]
11. Substance P increases sympathetic activity during combined angiotensin-converting enzyme and dipeptidyl peptidase-4 inhibition.
Devin JK; Pretorius M; Nian H; Yu C; Billings FT; Brown NJ
Hypertension; 2014 May; 63(5):951-7. PubMed ID: 24516103
[TBL] [Abstract][Full Text] [Related]
12. Bradykinin potentiation by angiotensin-(1-7) and ACE inhibitors correlates with ACE C- and N-domain blockade.
Tom B; de Vries R; Saxena PR; Danser AH
Hypertension; 2001 Jul; 38(1):95-9. PubMed ID: 11463767
[TBL] [Abstract][Full Text] [Related]
13. Local forearm vasodilation with intra-arterial administration of enalaprilat in humans.
Bank AJ; Kubo SH; Rector TS; Heifetz SM; Williams RE
Clin Pharmacol Ther; 1991 Sep; 50(3):314-21. PubMed ID: 1655327
[TBL] [Abstract][Full Text] [Related]
14. Hemodynamic and hormonal effects of quinaprilat in patients with congestive heart failure.
Mitrovic V; Mudra H; Bonzel T; Schmidt W; Strand JC; Bakovic-Alt R; Posvar EL
Clin Pharmacol Ther; 1996 Jun; 59(6):686-98. PubMed ID: 8681494
[TBL] [Abstract][Full Text] [Related]
15. Effect of angiotensin-converting enzyme inhibitors on endothelium-dependent peripheral vasodilation in patients with chronic heart failure.
Nakamura M; Funakoshi T; Arakawa N; Yoshida H; Makita S; Hiramori K
J Am Coll Cardiol; 1994 Nov; 24(5):1321-7. PubMed ID: 7930256
[TBL] [Abstract][Full Text] [Related]
16. Functional importance of angiotensin-converting enzyme-dependent in situ angiotensin II generation in the human forearm.
Saris JJ; van Dijk MA; Kroon I; Schalekamp MA; Danser AH
Hypertension; 2000 Mar; 35(3):764-8. PubMed ID: 10720592
[TBL] [Abstract][Full Text] [Related]
17. Local inhibition of converting enzyme and vascular responses to angiotensin and bradykinin in the human forearm.
Benjamin N; Cockcroft JR; Collier JG; Dollery CT; Ritter JM; Webb DJ
J Physiol; 1989 May; 412():543-55. PubMed ID: 2557432
[TBL] [Abstract][Full Text] [Related]
18. Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.
Cruden NL; Witherow FN; Webb DJ; Fox KA; Newby DE
Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1043-8. PubMed ID: 15105283
[TBL] [Abstract][Full Text] [Related]
19. Regulation of regional vascular tone: the role of angiotensin conversion in human forearm resistance vessels.
Webb DJ; Collier JG; Seidelin PH; Struthers AD
J Hypertens Suppl; 1988 Dec; 6(3):S57-9. PubMed ID: 2852237
[TBL] [Abstract][Full Text] [Related]
20. Measurement of angiotensin I converting enzyme inhibition in the heart.
Kinoshita A; Urata H; Bumpus FM; Husain A
Circ Res; 1993 Jul; 73(1):51-60. PubMed ID: 8389676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
